Department of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, Jiangsu, 210009, China.
Neurosurg Rev. 2024 Feb 24;47(1):92. doi: 10.1007/s10143-024-02328-w.
This study aimed to investigate the clinical characteristics of hemifacial spasm (HFS) after Bell's palsy and to evaluate the therapeutic efficacy of microvascular decompression (MVD).
A retrospective analysis was conducted on 18 patients who underwent MVD for HFS after Bell's palsy at our institution between January 1, 2017, and December 31, 2021. Clinical presentations, intraoperative findings, postoperative outcomes, and complications were comprehensively assessed.
Neurovascular compression (NVC) was identified in all the 18 patients. The offending vessels included anterior inferior cerebellar artery (AICA) in 6 patients (33.3%), posterior inferior cerebellar artery (PICA) in 7 patients (38.9%), vertebral artery (VA) combined with AICA in 3 patients (16.7%), and VA alongside PICA in 2 patients (11.1%). Notably, marked arachnoid membrane adhesion was evident in 11 patients (61.1%). 15(83.3%) patients were cured immediately after MVD, delayed relief was found in 3 (16.7%) patients. During the follow-up period, recurrence was not documented. Surgical complications were limited to facial paralysis in 3 patients and auditory impairment in 1 patient. No additional surgical complications were recorded.
In patients manifesting HFS after Bell's palsy, NVC predominantly underlies the etiology. MVD is a reliably safe and efficacious therapeutic intervention.
本研究旨在探讨贝尔氏面瘫后发生的面肌痉挛(HFS)的临床特征,并评估微血管减压术(MVD)的治疗效果。
对 2017 年 1 月 1 日至 2021 年 12 月 31 日期间在我院接受 MVD 治疗贝尔氏面瘫后 HFS 的 18 例患者进行回顾性分析。综合评估临床表现、术中发现、术后结果和并发症。
18 例患者均发现神经血管压迫(NVC)。致病血管包括小脑前下动脉(AICA)6 例(33.3%)、小脑后下动脉(PICA)7 例(38.9%)、椎动脉(VA)合并 AICA 3 例(16.7%)和 VA 伴 PICA 2 例(11.1%)。值得注意的是,11 例(61.1%)患者蛛网膜明显粘连。15 例(83.3%)患者 MVD 后即刻治愈,3 例(16.7%)患者延迟缓解。随访期间无复发。手术并发症仅限于 3 例患者面瘫和 1 例患者听力障碍。无其他手术并发症记录。
在贝尔氏面瘫后出现 HFS 的患者中,NVC 是主要病因。MVD 是一种可靠的安全有效的治疗干预措施。